newsfilter
← Latest News
PR Newswire·

Crown Laboratories and Revance Therapeutics Announce Expiration of Tender Offer

Crown Laboratories, Inc. ("Crown") and Revance Therapeutics, Inc. (NASDAQ: RVNC) ("Revance"), today announced that the tender offer to purchase all...